Malignant metastatic melanoma in brain with unknown primary origin: a case report
Headaches, lethargy, vomiting, and altered sensorium should prompt investigation for brain metastases from melanoma, even without a detectable primary tumor. Treatment strategies including immunotherapy and stereotactic surgery aim for a median survival of 8-10 months. Socio-economic factors, as highlighted in this case, significantly affect treatment access and patient outcomes.
Authors
- Maya Bhattachan (ORCID: https://orcid.org/0000-0003-1916-1958)
- Gopal Sedain (ORCID: https://orcid.org/0000-0002-8184-3303)
- Binod Rajbhandari (ORCID: https://orcid.org/0000-0002-4165-8584)
- Samriddhi Parajuli
- Asim Pandey (ORCID: https://orcid.org/0009-0004-5747-0836)
- N. D. Pandey (ORCID: https://orcid.org/0009-0008-8715-2256)
- Kunjan Khanal (ORCID: https://orcid.org/0009-0006-1181-8782)
- Pasang Lamu Sherpa (ORCID: https://orcid.org/0009-0000-5343-1398)
Institutions
- Tribhuvan University Teaching Hospital (NP)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1097/ms9.0000000000002562
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00